360. Enhanced Alpha-1 Antitrypsin (AAT) Expression and Decrease Immune Response With Isolated Limb Perfusion (ILP) Delivery of rAAV1-CB-hAAT

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)36164-0
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Therapeutic Isolated Limb Perfusion (ILP) in the Management of Patients With Advanced or Recurrent Limb Melanoma

Irish Journal of Medical Science
Medicine
2011English

Alpha 1-Antitrypsin-Labor Und Alpha 1-Antitrypsin-Register

Pneumologie
MedicinePulmonaryRespiratory Medicine
2004English

Α1-Antitrypsin (SERPINA1; AAT; A1AT)

Science-Business eXchange
2010English

Safety and Efficacy of Alpha-1-Antitrypsin Augmentation Therapy in the Treatment of Patients With Alpha-1-Antitrypsin Deficiency

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Alpha-1-Antitrypsin Deficiency

2020English

Alpha-1-Antitrypsin Genotyping With Mouthwash Specimens

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2001English

Alpha-1 Antitrypsin Deficiency

Journal of insurance medicine (New York, N.Y.)
Medicine
2015English

Alpha‐1‐Antitrypsin Deficiency

English

Improving Engraftment of Hepatocyte Transplantation Using Alpha-1 Antitrypsin as an Immune Modulator

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy